2021
First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System
12/15/2021
VANCOUVER, British Columbia – Kardium Inc. announces the completion of successful first-in-human (FIH) procedures with the Globe Pulsed Field System. Dr. Vivek Reddy of Mount Sinai Hospital in New York, USA and Prof. Petr Neužil of Na Homolce Hospital in Prague, Czech Republic, performed the procedures in Prague last week. Dr. Jacob Koruth of Mount Sinai Hospital […]
Kardium selected as Medical/Digital Technology Company of the Year
08/05/2021
Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.
More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory
07/20/2021
Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.
01/25/2021
Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.
Kardium announces $115M in new financing for innovative atrial fibrillation treatment
01/25/2021
VANCOUVER, British Columbia – Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc. […]